Personalized peptide-based vaccination for treatment of colorectal cancer: rational and progress

Parizadeh, Seyed, Jafarzadeh-Esfehani, Reza, Ghandehari, Maryam, Rezaei-Kalat, Afsaneh, Javanbakht, Afsane, Hassanian, Seyed, Ferns, Gordon A, Khazaei, Majid and Avan, Amir (2019) Personalized peptide-based vaccination for treatment of colorectal cancer: rational and progress. Current Drug Targets, 20 (1). ISSN 1389-4501

[img] PDF - Accepted Version
Download (359kB)


Colorectal cancer (CRC) is one of the most common cancers globally and is associated with a high rate of morbidity and mortality. A large proportion of patients with early stage CRC who undergo conventional treatments develop local recurrence or distant metastasis and in this group of advanced disease, the survival rate is low. Furthermore there is often a poor response and/or toxicity associated with chemotherapy and chemo-resistance may limit continuing conventional treatment alone. Choosing novel and targeted therapeutic approaches based on clinicopathological and molecular features of tumors in combination with conventional therapeutic approach could be used to eradicate residual micrometastasis and therefore improve patient prognosis and also be used preventively. Peptide-based vaccination therapy is one class of cancer treatment that could be used to induce tumor-specific immune responses, through the recognition of specific antigen-derived peptides in tumor cells, and this has emerged as a promising anti-cancer therapeutic strategy. The aim of this review was to summarize the main findings of recent studies in exciting field of peptide-based vaccination therapy in CRC patients as a novel therapeutic approach in treatment of CRC.

Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Division of Medical Education
Subjects: R Medicine
Depositing User: Cherie Elody
Date Deposited: 17 Jul 2019 10:32
Last Modified: 19 Jun 2020 01:00

View download statistics for this item

📧 Request an update